Lessons From WHI, Part 3: Cost-EffectivenessLessons From WHI, Part 3: Cost-Effectiveness
Drs. Black and Jackson discuss a new cost analysis that demonstrates the value of the WHI hormone therapy study. Medscape Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2014 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Lessons From the WHI -- Part 1: Hormone TherapyLessons From the WHI -- Part 1: Hormone Therapy
In part 1 of Dr. Black's interview with Dr. Rebecca Jackson, they review the landmark Women's Health Initiative findings on hormone therapy. Medscape Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2014 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Lessons From the WHI, Part 1: Hormone TherapyLessons From the WHI, Part 1: Hormone Therapy
In part 1 of Dr. Black's interview with Dr. Rebecca Jackson, they review the landmark Women's Health Initiative findings on hormone therapy. Medscape Cardiology (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - July 8, 2014 Category: OBGYN Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

HRT Treatments / NHR Hormone Therapy and Weight Loss Plans Announces...
HRT Treatments / NHR Hormone Therapy and Weight Loss Plans now offers home progesterone testing kits and evaluation, offering simple hormone testing done safely from each client’s home.(PRWeb July 03, 2014)Read the full story at http://www.prweb.com/releases/hormone-testing/progesterone-cream/prweb11993572.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 3, 2014 Category: Pharmaceuticals Source Type: news

Largest Study to Date: Transgender Hormone Treatment Safe Largest Study to Date: Transgender Hormone Treatment Safe
A multicenter study of more than 1500 patients receiving cross-sex hormone therapy for at least a year showed that most side effects were minor, providing reassurance on safety. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 2, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

PSMA-based imaging traces even treatment-resistant prostate cancer
(Society of Nuclear Medicine) Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized -- but some cases simply do not respond to this treatment. A groundbreaking molecular imaging agent has been developed to help clinicians find as much cancer as possible, whether it is responding favorably or not, in an effort to improve clinical decision making for these patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 9, 2014 Category: Cancer & Oncology Source Type: news

The 5 Types of Breast Cancer Treatment Options
After your breast cancer has been diagnosed, your healthcare team will recommend treatment. There are five standard treatment options for breast cancer: surgery, chemotherapy, radiation, targeted biologic, and hormonal therapy. Learn about each one, and how a decision on which is right for you is made. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - June 6, 2014 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news

ASCO: Oreronel Fails to Boost Prostate Cancer Survival
CHICAGO (MedPage Today) -- The novel anti-androgen orteronel delayed progression in chemotherapy-naive metastatic prostate cancer refractory to standard hormone therapy, but without a survival benefit. (Source: MedPage Today Urology)
Source: MedPage Today Urology - June 5, 2014 Category: Urology & Nephrology Source Type: news

ASCO: Orteronel Fails to Boost Prostate Cancer Survival
CHICAGO (MedPage Today) -- The novel anti-androgen orteronel delayed progression in chemotherapy-naive metastatic prostate cancer refractory to standard hormone therapy, but without a survival benefit. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 5, 2014 Category: Geriatrics Source Type: news

ASCO: Combo Hormone Tx Promising in Prostate Cancer
CHICAGO (MedPage Today) -- A combination attack on androgens in metastatic prostate cancer resistant to initial hormone therapy drove down testosterone levels and appeared safe, according to a proof of concept study. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 3, 2014 Category: Primary Care Source Type: news

Practice-Changing Results for Metastatic Prostate CancerPractice-Changing Results for Metastatic Prostate Cancer
For patients with metastatic hormone-sensitive prostate cancer, upfront chemotherapy with docetaxel, given at the same time as hormone therapy, prolongs survival, new research shows. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

10 Years of Hormones for Breast Cancer, ASCO Says (CME/CE)
(MedPage Today) -- All women with hormone receptor-positive breast cancer should have the option to continue adjuvant hormonal therapy for as long as a decade, according to an updated guideline from the American Society of Clinical Oncology. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - May 28, 2014 Category: Geriatrics Source Type: news

SNRI Equal to Hormones for Hot Flush Tx
(MedPage Today) -- A low dose of the serotonin-norepinephrine reuptake inhibitor venlafaxine (Effexor) appeared roughly as good as hormonal therapy to ease hot flushes in menopause, a randomized trial showed. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 27, 2014 Category: Psychiatry Source Type: news

Fighting cancer with dietary changes
Calorie restriction during treatment for breast cancer changes cellular programming in a way that lowers the chance of metastases in mice. Breast cancer patients are often treated with hormonal therapy to block tumor growth, and steroids to counteract the side effects of chemotherapy. However, both treatments can cause a patient to have altered metabolism which can lead to weight gain. In fact, women gain an average of 10 pounds in their first year of treatment. Recent studies have shown that too much weight makes standard treatments for breast cancer less effective, and those who gain weight during treatment have worse ca...
Source: ScienceDaily Headlines - May 26, 2014 Category: Science Source Type: news

Stage 4 prostate cancer hormone therapy
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - May 20, 2014 Category: Consumer Health News Source Type: news

Treatment of Gastroenteropancreatic Neuroendocrine TumorsTreatment of Gastroenteropancreatic Neuroendocrine Tumors
Neuroendocrine tumor treatment now includes hormone therapy, chemotherapy, and targeted biologic therapy. Endocrine Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 15, 2014 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy: Study
Title: Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy: StudyCategory: Health NewsCreated: 5/14/2014 5:36:00 PMLast Editorial Review: 5/15/2014 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 15, 2014 Category: Cancer & Oncology Source Type: news

A Study on Prostate Cancer Relapses Suggests That Hormone Therapy Can Wait
Such therapy can cause side effects like hot flashes, loss of libido and weakening of muscles and bones. (Source: NYT Health)
Source: NYT Health - May 15, 2014 Category: Consumer Health News Authors: By ANDREW POLLACK Tags: Pfizer Inc PFE NYSE Roche Holding A G RHHBY Other OTC Prostate Cancer Bristol Myers Squibb Company BMY NYSE Tests (Medical) Source Type: news

Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy: Study
Even if PSA levels are rising, postponing the treatment may boost quality of life without lowering survival (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 15, 2014 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Endocrinology, Family Medicine, Nursing, Oncology, Pharmacy, Reproductive Medicine, News, Source Type: news

Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy
Even if PSA levels are rising, postponing the treatment may boost quality of life without lowering survival Source: HealthDay Related MedlinePlus Page: Prostate Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 14, 2014 Category: Consumer Health News Source Type: news

“A Study on Prostate Cancer Relapses Suggests that Hormone Therapy Can Wait,”
This article features commentary from physicians at Dana-Farber/Brigham and Women’s Cancer Center and Moffitt Cancer Center-two of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 14, 2014 Category: Cancer & Oncology Source Type: news

Early menopause linked to mental decline
Conclusion This study found a link between premature menopause and memory problems. Strengths of the study include the large number of participants and the fact they were followed prospectively, which reduces the chance of bias. However, as it was a cohort study, it cannot prove that the memory problems were caused by their premature menopause. The researchers analysed the results, taking multiple factors into consideration. Patient recall, the age of menopause and the type and duration of taking any hormonal therapy may also have been inaccurate. A further limiting factor in this study is that it commenced when women were...
Source: NHS News Feed - May 8, 2014 Category: Consumer Health News Tags: Neurology Lifestyle/exercise Cancer Source Type: news

Combined hormone therapy clinical trial yields massive economic return
The overall economic return from a combined hormone therapy clinical trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published. "The motivation for the first WHI trial was to see if we could prevent heart disease, the number one killer of women. That's why we did it -- the economics never occurred to me," said the lead investigator. What these findings underscore is the significant role clinical trials play in science and the importance of continuing to find ways to strategically invest public res...
Source: ScienceDaily Headlines - May 6, 2014 Category: Science Source Type: news

WHI reports $37.1B economic return on combined hormone therapy clinical trial
(Fred Hutchinson Cancer Research Center) The overall economic return from the Women's Health Initiative E+P trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 5, 2014 Category: Cancer & Oncology Source Type: news

WHI reports $37.1 billion economic return on combined hormone therapy clinical trial
(Fred Hutchinson Cancer Research Center) The overall economic return from the Women's Health Initiative E+P trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 5, 2014 Category: Cancer & Oncology Source Type: news

HRT Treatments / Diet Doc Hormone Replacement & Weight Loss Plans...
Diet Doc now offers patients a great new way to test for hormonal imbalance that may be causing weight gain, or hindering weight loss, with new Weight Management Profile hormone testing kits, done...(PRWeb April 25, 2014)Read the full story at http://www.prweb.com/releases/hormone-therapy/weight-loss/prweb11795003.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 26, 2014 Category: Pharmaceuticals Source Type: news

HRT Treatments / Diet Doc Hormone Therapy & Weight Loss Plans...
Diet Doc now offers hormone replacement therapy, utilizing bio-identical hormones to relieve symptoms of hormonal imbalance. Test kits are sent directly to the patient’s home, and results are...(PRWeb April 19, 2014)Read the full story at http://www.prweb.com/releases/hormone-replacement/hormonal-imbalance/prweb11777897.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 19, 2014 Category: Pharmaceuticals Source Type: news

Six months hormone therapy in addition to radiotherapy improves prostate cancer survival (Medical Xpress, 7 April 2014)
A French study presented at the 33rd conference of the European Society for Radiotherapy and Oncology in Vienna assessed prostate cancer survival rates for men undergoing radiotherapy combined with androgen deprivation therapy. Full article (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 8, 2014 Category: Endocrinology Source Type: news

Hormone therapy linked to lower non-Hodgkin lymphoma risk
Menopausal hormone therapy use is linked to a lower risk of B-cell non-Hodgkin lymphoma, research has found. "The connection between lymphomas and menopausal hormone therapy use hinges on understanding the disease's biology and the window of susceptibility," the lead researcher said. "Hormone therapy is of interest because the loss of estrogen coupled with aging in women result in decreased immune function, which can elevate risk of non-Hodgkin lymphoma." (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 7, 2014 Category: Science Source Type: news

Six months hormone therapy in addition to radiotherapy improves prostate cancer survival
(European Society for Radiotherapy and Oncology (ESTRO)) Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research to be presented at the 33rd conference of the European Society for Radiotherapy and Oncology in Vienna. The findings are expected to change clinical practice. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 6, 2014 Category: Cancer & Oncology Source Type: news

Intimacy and Sex After Cancer Treatment is Over
Intimacy and sex after cancer treatment is over Emotions can have a strong effect on your desire for sex due to anxiety, fears and physical changes during and after cancer treatment. Be patient as you heal. Hormone therapy for breast cancer Get the facts about this treatment for breast cancers that are sensitive to hormones. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 24, 2014 Category: Databases & Libraries Source Type: news

Some Breast Cancers Require Longer Tx
(MedPage Today) -- Breast cancers with high-level estrogen sensitivity had a significantly greater risk of late recurrence, possibly indicating a need for more than 5 years of adjuvant hormonal therapy, British investigators reported. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 21, 2014 Category: Primary Care Source Type: news

Extended hormone therapy may help some women with ER+ breast cancer
Genetic analyses of results from 1125 postmenopausal women being treated for oestrogen responsive breast cancer have shown that some of them are more likely than others to have a late recurrence of their cancer and might benefit from ten years of hormone therapy rather than five. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 21, 2014 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Menopause hormone therapy: Pros and cons
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - March 21, 2014 Category: Consumer Health News Source Type: news

Genetic testing may help select women with ER+ breast cancer for extended hormone therapy
(ECCO-the European CanCer Organisation) Genetic analyses of results from 1125 postmenopausal women being treated for oestrogen responsive breast cancer have shown that some of them are more likely than others to have a late recurrence of their cancer and might benefit from ten years of hormone therapy rather than five. The research is presented at the European Breast Cancer Conference in Glasgow. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2014 Category: Global & Universal Source Type: news

Finding the Cure for Age in One Injection
Looking for the Elixir of Youth--in One Shotread more (Source: Psychology Today Sex Center)
Source: Psychology Today Sex Center - March 19, 2014 Category: Sexual Medicine Authors: Randi Hutter Epstein, M.D. Tags: Health Sex hormone therapy rejuvenation testosterone therapy Source Type: news

In postmenopausal women at risk for dementia, estradiol preserves key brain regions
When initiated soon after menopause, hormone therapy with estradiol prevented degeneration in key brain regions of women who were at heightened dementia risk, according to a new study led by Stanford University School of Medicine researchers.The investigators also found that another type of hormone therapy, marketed under the brand name Premarin, was far less protective. Premarin is a mixture of 30-plus substances derived from the urine of pregnant mares. Estradiol - the dominant sex-steroid hormone in woman - accounts for about 17 percent of Premarin's total content. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 14, 2014 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

Better survival after lung cancer diagnosis in women linked to hormone therapy
Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference. The combination of estrogen plus progesterone and the use of long-term hormone therapy were associated with the most significant improvements in survival.The study was designed to explore the influence of several reproductive and hormonal factors on overall survival of women with non-small cell lung cancer (NSCLC). (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 28, 2014 Category: Consumer Health News Tags: Lung Cancer Source Type: news

UCLA study finds robotic-assisted prostate surgery offers better cancer control
An observational study from UCLA's Jonsson Comprehensive Cancer Center has found that prostate cancer patients who undergo robotic-assisted prostate surgery have fewer instances of cancer cells at the edge of their surgical specimen and less need for additional cancer treatments like hormone or radiation therapy than patients who have traditional "open" surgery.   The study, published online Feb. 19 in the journal European Urology, was led by Dr. Jim Hu, UCLA's Henry E. Singleton Professor of Urology and director of robotic and minimally invasive surgery in the urology department at the David Geffen School o...
Source: UCLA Newsroom: Health Sciences - February 28, 2014 Category: Universities & Medical Training Source Type: news

Hormone therapy linked to better survival after lung cancer diagnosis in women
Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference. The combination of estrogen plus progesterone and the use of long-term hormone therapy were associated with the most significant improvements in survival. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 26, 2014 Category: Science Source Type: news

Hormone therapy linked to better survival after lung cancer diagnosis in women
(International Association for the Study of Lung Cancer) Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference. The combination of estrogen plus progesterone and the use of long-term hormone therapy were associated with the most significant improvements in survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 26, 2014 Category: Cancer & Oncology Source Type: news

Moderate Exercise Cuts Women's Stroke Risk, Helps Offset Increase Risk from Hormone Therapy
Source: American Heart Association Related MedlinePlus Pages: Hormone Replacement Therapy, Stroke (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 14, 2014 Category: Consumer Health News Source Type: news

Exercise Cuts Stroke Risk From Hormone Therapy (CME/CE)
(MedPage Today) -- Exercise may moderately shave off some of the increased risk of hormone therapy, researchers found. (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - February 13, 2014 Category: OBGYN Source Type: news

Prostate cancer advance could improve treatment options
Researchers have made an important advance in understanding genetic changes associated with terminal prostate cancer. The research highlights why relapses could happen in some men following hormone therapy. And it could help identify those patients that will develop fatal prostate cancer much earlier for life-extending therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 12, 2014 Category: Science Source Type: news

Prostate cancer advance could improve treatment options
(University of East Anglia) Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer. The research highlights why relapses could happen in some men following hormone therapy. And it could help identify those patients that will develop fatal prostate cancer much earlier for life-extending therapy. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 12, 2014 Category: Biology Source Type: news

Researchers discover new hormone receptors to target when treating breast cancer
(Brigham and Women's Hospital) The findings offer the possibility of expanding the ways patients with breast cancer are treated with hormone therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 4, 2014 Category: Cancer & Oncology Source Type: news

More than one-third of women have hot flashes 10 years after menopause
A team of researchers has found that moderate to severe hot flashes continue, on average, for nearly five years after menopause, and more than a third of women experience moderate/severe hot flashes for 10 years or more after menopause. Current guidelines recommend that hormone therapy, the primary medical treatment for hot flashes, not continue for more than 5 years. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 30, 2014 Category: Science Source Type: news

Postmenopausal Hormone Therapy Linked to Acute Pancreatitis (FREE)
By Amy Orciari Herman Postmenopausal women who use systemic hormone therapy face increased risk for acute pancreatitis, according to a prospective study in the Canadian Medical Association Journal.Over 31,000 postmenopausal women in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 28, 2014 Category: Primary Care Source Type: news

Hormone Therapy May Cut Risk of Repeat Joint Replacement Surgery in Women
Title: Hormone Therapy May Cut Risk of Repeat Joint Replacement Surgery in WomenCategory: Health NewsCreated: 1/23/2014 12:35:00 PMLast Editorial Review: 1/24/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 24, 2014 Category: Rheumatology Source Type: news